Mediclinic International plc (LON:MDC – Get Rating) insider Tom Singer acquired 20,000 shares of the company’s stock in a transaction dated Wednesday, May 25th. The shares were bought at an average cost of GBX 366 ($4.61) per share, with a total value of £73,200 ($92,110.23).
Shares of LON MDC traded up GBX 15.80 ($0.20) on Wednesday, reaching GBX 370.80 ($4.67). 1,243,845 shares of the company traded hands, compared to its average volume of 649,733. Mediclinic International plc has a fifty-two week low of GBX 271.40 ($3.42) and a fifty-two week high of GBX 395.40 ($4.98). The company has a 50 day moving average of GBX 363.71 and a 200 day moving average of GBX 336.59. The company has a current ratio of 1.88, a quick ratio of 1.73 and a debt-to-equity ratio of 81.42. The stock has a market capitalization of £2.73 billion and a PE ratio of 22.94.
The business also recently disclosed a dividend, which will be paid on Friday, August 26th. Stockholders of record on Thursday, August 4th will be paid a dividend of GBX 3 ($0.04) per share. This represents a dividend yield of 0.85%. The ex-dividend date of this dividend is Thursday, August 4th.
Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers acute care, specialist-orientated, and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 74 hospitals, 18 day case clinics, 18 outpatient clinics, 5 subacute hospitals, 2 mental health facilities, and 454 theatres with approximately 11,?449 inpatient beds in Switzerland, South Africa, Namibia, and the United Arab Emirates.
- Agilent Technologies Is Bottoming But Don’t Buy It Yet
- Institutions Ring The Register On Toll Brothers Stock
- Dick’s Sporting Goods Falls Flat On Weak Guidance
- It’s Time to Buy into Planet Fitness Stock
- Indie Semiconductor Stock is Putting in a Bottom
Receive News & Ratings for Mediclinic International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mediclinic International and related companies with MarketBeat.com's FREE daily email newsletter.